Two sides of the same coin: Stem cells in cancer and regenerative medicine

FASEB Journal

Volumn 28, Issue 7, 2014, Pages 2748-2761

  Ilmer, Matthias ^a   Vykoukal, Jody ^a   Boiles, Alejandro Recio ^a   Coleman, Michael ^b   Alt, Eckhard ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b InGeneron Inc   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelialmesenchymal transition; Exosomes; Mesenchymal stromal cells; Warburg

Indexed keywords

ANGIOGENESIS; CANCER STEM CELL; CARCINOGENESIS; CELL COMMUNICATION; CELL METABOLISM; ENDOCRINE FUNCTION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; NEOPLASM; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL; TUMOR MICROENVIRONMENT;

EPITHELIAL-MESENCHYMAL TRANSITION; EXOSOMES; MESENCHYMAL STROMAL CELLS; WARBURG;

HUMANS; NEOPLASMS; REGENERATIVE MEDICINE; STEM CELLS;

EID: 84903709222     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-244640     Document Type: Review

References (121)

1. Prockop, D. J. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74 (Pubitemid 27161245)
2. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147 (Pubitemid 29282067)
3. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D. J., and Horwitz, E. (2006) Minimal criteria for defining multipo-tent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317 (Pubitemid 44269669)
4. Phinney, D. G., and Prockop, D. J. (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25, 2896-2902 (Pubitemid 350127874)
5. Peroni, D., Scambi, I., Pasini, A., Lisi, V., Bifari, F., Krampera, M., Rigotti, G., Sbarbati, A., and Galiè, M. (2008) Stem molecular signature of adipose-derived stromal cells. Exp. Cell Res. 314, 603-615
6. Wu, Y., Zhao, R. C, and Tredget, E. E. (2010) Concise review: bone marrow derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells 28, 905-915
7. Dvorak, H. F. (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659 (Pubitemid 17052899)
8. Muehlberg, F. L., Song, Y. H., Krohn, A., Pinilla, S. P., Droll, L. H., Leng, X., Seidensticker, M., Ricke, J., Altman, A. M., Devarajan, E., Liu, W., Arlinghaus, R. B., and Alt, E. U. (2009) Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30, 589-597
9. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70 (Pubitemid 30046295)
10. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
11. Zhang, Y., Daquinag, A., Traktuev, D. O., Amaya-Manzanares, F., Simmons, P. J., March, K. L., Pasqualini, R., Arap, W., and Kolonin, M. G. (2009) White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res. 69, 5259-5266
12. Jotzu, C, Alt, E., Welte, G., Li, J., Hennessy, B. T., Devarajan, E., Krishnappa, S., Pinilla, S., Droll, L., Song, Y H. (2011) Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors. Cell. Oncol. (Dordr.) 34, 55-67
13. Pinilla, S., Alt, E., Khalek, F. J. A., Jotzu, C., Muehlberg, F., Beckmann, C, and Song, Y. H. (2009) Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett. 284, 80-85
14. Krohn, A., Song, Y.-H., Muehlberg, F., Droll, L., Beckmann, C, and Alt, E. (2009) CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro. Cancer Lett. 280, 65-71
15. Antsiferova, M., and Werner, S. (2012) The bright and the dark sides of activin in wound healing and cancer. J. Cell Sci. 25, 3929-3937
16. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., and Weinberg, R. A. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563 (Pubitemid 47525152)
17. Kim, M. Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H., Norton, L., and Massagué, J. (2009) Tumor self-seeding by circulating cancer cells. Cell 139, 1315-1326
18. O'Connell, J. T., Sugimoto, H., Cooke, V. G., MacDonald, B. A., Mehta, A. I., LeBleu, V. S., Dewar, R., Rocha, R. M., Brentani, R. R., Resnick, M. B., Neilson, E. G., Zeisberg, M., and Kalluri, R. (2011) VEGF-A and tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc. Natl. Acad. Sci. U.S.A. 108, 16002-16007
19. Oskarsson, T., and Massagué, J. (2011) Extracellular matrix players in metastatic niches. EMBOJ. 31, 254-256
20. Oskarsson, T., Acharyya, S., Zhang, X. H.-F., Vanharanta, S., Tavazoie, S. F., Morris, P. G., Downey, R.J., Manova-Todorova, K., Brogi, E., and Massagué, J. (2011) Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 17, 867-874
21. Kojima, Y, Acar, A., Eaton, E. N., Mellody, K. T., Scheel, C, Ben-Porath, I., Onder, T. T., Wang, Z. C, Richardson, A. L., Weinberg, R. A., and Orimo, A. (2010) Autocrine TGF-ß and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc. Natl. Acad. Sci. U.S.A. 107, 20009-20014
22. Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., and Heeschen, C. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323 (Pubitemid 47355323)
23. Singh, S., Srivastava, S. K., Bhardwaj, A., Owen, L. B., and Singh, A. P. (2010) CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. Br. J. Cancer 103, 1671-1679
24. Quante, M., Tu, S. P., Tomita, H., Gonda, T., Wang, S. S., Takashi, S., Baik, G. H., Shibata, W., Diprete, B., Betz, K. S., Friedman, R., Varro, A., Tycko, B., and Wang, T. C. (2011) Bone marrow-derived myofibroblasts contribute to the mesen-chymal stem cell niche and promote tumor growth. Cancer Cell. 19, 257-272
25. Warburg, O., Posener, K., and Negelein, E. (1924) Ueber den stoffwechsel der tumoren. Biochem. Z. 152, 319-344
26. Lunt, S. Y., and Vander Heiden, M. G. (2011) Aerobic glycol-ysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441-464
27. Martinez-Outschoorn, U. E., Lisanti, M. P., and Sotgia, F. (2014) Catabolic cancer-associated fibroblasts (CAFs) transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin. Cancer Biol. doi:10.1016/j.semcancer.2014.01.005
28. Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., Pestell, R. G., Martinez-Outschoorn, U. E., Sotgia, F., and Lisanti, M. P. (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8, 3984-4001
29. Ohkouchi, S., Block, G. J., Katsha, A. M., Kanehira, M., Ebina, M., Kikuchi, T., Saijo, Y., Nukiwa, T., and Prockop, D. J. (2011) Mesenchymal stromal cells protect cancer cells from ROS-induced apoptosis and enhance the Warburg effect by secreting sTC1. Mol. Ther. 20, 417-423
30. Block, G. J., DiMattia, G. D., and Prockop, D. J. (2010) Stanniocalcin-1 regulates extracellular ATP-induced calcium waves in human epithelial cancer cells by stimulating ATP release from bystander cells. PLoS One 5, e10237
31. Bonnet, D., and Dick, J. E. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737 (Pubitemid 27298715)
32. Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., Yamada, S. D., Peter, M. E., Gwin, K., and Lengyel, E. (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498-1503
33. Hamburger, A. W., and Salmon, S. E. (1977) Primary bioassay of human tumor stem cells. Science 197, 461-463
34. Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., Jung, Y., Dontu, G., Taichman, R., and Wicha, M. S. (2011) Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 71, 614-624
35. Malanchi, I., Santamaria-Martínez, A., Susanto, E., Lehr, H. A., Delaloye, J. F., and Huelsken, J. (2011) Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89
36. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983-3988 (Pubitemid 36418143)
37. Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., Guan, J. L., Dontu, G., and Wicha, M. S. (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest. 120, 485-497
38. Vermeulen, L., De Sousa, E., Melo, F., Richel, D. J., and Medema, J. P. (2012) The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol. 13, e83-e89
39. Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., and Stassi, G. (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1, 389-402 (Pubitemid 47506537)
40. Vermeulen, L., De Sousa, E., Melo, F., van der Heijden, M., Cameron, K, de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C, Rodermond, H., Sprick, M. R., Kemper, K, Richel, D. J., Stassi, G., and Medema, J. P. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12, 468-476
41. Chen, J., Chen, Z., Chen, M., Li, D., Li, Z., Xiong, Y., Dong, J., and Li, X. (2009) Role of fibrillar tenascin-C in metastatic pancreatic cancer. Int. J. Oncol. 34, 1029-1036
42. Kong, B., Michalski, C. W., Erkan, M., Friess, H., and Kleeff, J. (2011) From tissue turnover to the cell of origin for pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 8, 467-472
43. Baril, P., Gangeswaran, R., Mahon, P. C, Caulee, K, Kocher, H. M., Harada, T., Zhu, M., Kalthoff, H., Crnogorac-Jurcevic, T., and Lemoine, N. R. (2006) Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the ß4 integrin and the PI3K pathway. Oncogene 26, 2082-2094 (Pubitemid 46514745)
44. Heo, S. C, Lee, K O., Shin, S. H., Kwon, Y. W., Kim, Y M., Lee, C. H., Kim, Y. D., Lee, M. K, Yoon, M. S., and Kim, J. H. (2011) Periostin mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth in a xenograft lung adenocarcinoma model. Biochim. Biophys. Acta 1813, 2061-2070
45. Peinado, H., Lavotshkin, S., and Lyden, D. (2011) The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21, 139-146
46. Valenta, T., and Hausmann, G. (2012) The many faces and functions of ß-catenin. EMBOJ. 31, 2714-2736.
47. Thiery, J. P., Acloque, H., Huang, R. Y. J., and Nieto, M. A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890
48. Chao, Y L., Shepard, C. R., and Wells, A. (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol. Cancer 9, 179
49. Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., and Williams, E. D. (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 66, 11271-11278 (Pubitemid 46009956)
50. Brabletz, T. (2012) To differentiate or not-routes towards metastasis. Nat. Rev. Cancer 12, 425-436
51. Thompson, E. W., and Haviv, I. (2011) The social aspects of EMT-MET plasticity. Nat. Med. 17, 1048-1049
52. Scheel, C., Eaton, E. N., Li, S. H.-J., Chaffer, C. L., Reinhardt, F., Kah, K J., Bell, G., Guo, W., Rubin, J., Richardson, A. L., and Weinberg, R. A. (2011) Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145, 926-940
53. Maier, H. J., Wirth, T., and Beug, H. (2010) Epithelialmesenchymal transition in pancreatic carcinoma. Cancers 2, 2058-2083
54. Morrison, C. D., Parvani, J. G., and Schiemann, W. P. (2013) The relevance of the TGF-ß paradox to EMT-MET programs. Cancer Lett. 341, 30-40
55. Kong, D., Wang, Z., Sarkar, S. H., Li, Y., Banerjee, S., Saliga-nan, A., Kim, H. R., Cher, M. L., and Sarkar, F. H. (2008) Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells 26, 1425-1435
56. Junk, D. J., Cipriano, R., and Bryson, B. L. (2013) Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events. Neoplasia 15, 1100-1109
57. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A, and Ratajczak, M. Z. (2006) Membrane-derived mi-crovesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495 (Pubitemid 44264090)
58. Cho, J. A., Park, H., Lim, E. H., Choi, J. S., Lee, J. H., Shin, J. W., and Lee, K W. (2011) Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol. Oncol. 123, 379-386
59. Peinado, H., Aleckovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C, García-Santos, G., Ghajar, C., Nitadori-Hoshino, A., Hoffman, C., Badal, K, Garcia, B. A., Callahan, M. K, Yuan, J., Martins, V. R., Skog, J., Kaplan, R. N., Brady, M. S., Wolchok, J. D., Chapman, P. B., Kang, Y., Bromberg, J., and Lyden, D. (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891
60. Yuan, X.-L., Chen, L., Li, M.-X., Dong, P., Xue, J., Wang, J., Zhang, T. T., Wang, X. A., Zhang, F. M., Ge, H. L., Shen, L. S., and Xu, D. (2010) Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin. Immunol. 134, 277-288
61. + T cells promote development of cancer-initiating cells in colorectal cancer. J. Leukoc. Biol. 89, 85-91
62. Patel, S. A., Meyer, J. R., Greco, S. J., Corcoran, K. E., Bryan, M., and Rameshwar, P. (2010) Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-ß. J. Immunol. 184, 5885-5894
63. Hanahan, D., and Coussens, L. M. (2012) Accessories to the crime: functions of cells recruited to the tumor microenviron-ment. Cancer Cell21, 309-322
64. Beckermann, B. M., Kallifatidis, G., Groth, A., Frommhold, D., Apel, A., Mattern, J., Salnikov, A. V., Moldenhauer, G., Wagner, W., Diehlmann, A., Saffrich, R., Schubert, M., Ho, A. D., Giese, N., Büchler, M. W., Friess, H., Büchler, P., and Herr, I. (2008) VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br. J. Cancer99, 622-631
65. Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K. E., Geber, A., Fligelman, B., Leversha, M., Brennan, C., and Tabar, V. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468, 829-833
66. Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., and De Maria, R. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468, 824-828
67. Xue, Y., Lim, S., Yang, Y, Wang, Z., Jensen, L. D., Hedlund, E. M., Andersson, P., Sasahara, M., Larsson, O., Galter, D., Cao, R, Hosaka, K., and Cao, Y. (2011) PDGF-BB modulates hema-topoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nat. Med. 18, 100-110
68. Gehmert, S., Gehmert, S., Prantl, L., Vykoukal, J., Alt, E., and Song, Y.-H. (2010) Breast cancer cells attract the migration of adipose tissue-derived stem cells via the PDGF-BB/PDGFR-ß signaling pathway. Biochem. Biophys. Res. Commun. 398, 601-605
69. Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., Leach, S. D., and Stanger, B. Z. (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361
70. Hüsemann, Y., Geigl, J. B., Schubert, F., Hüsemann, Y, Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T., Riethmüller, G., and Klein, C. A. (2008) Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68 (Pubitemid 350309740)
71. Studeny, M., Marini, F. C, Champlin, R. E., Zompetta, C, Fidler, I. J., and Andreeff, M. (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-ß delivery into tumors. Cancer Res. 62, 3603-3608 (Pubitemid 34728832)
72. Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C, Cabreira-Hansen, M., Bekele, B. N., Champlin, R. E., and Andreeff, M. (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 96, 1593-1603 (Pubitemid 39534883)
73. Loebinger, M. R., Sage, E. K., Davies, D., and Janes, S. M. (2010) TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population. Br. J. Cancer 103, 1692-1697
74. Grisendi, G., Bussolari, R., Cafarelli, L., Petak, I., Rasini, V., Veronesi, E., De Santis, G., Spano, C, Tagliazzucchi, M., Barti-Juhasz, H., Scarabelli, L., Bambi, F., Frassoldati, A., Rossi, G., Casali, C, Morandi, U., Horwitz, E. M., Paolucci, P., Conte, P., and Dominici, M. (2010) Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res. 70, 3718-3729
75. Mohr, A., Albarenque, S. M., Deedigan, L., Yu, R., Reidy, M., Fulda, S., and Zwacka, R. M. (2010) Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells. Stem Cells 28, 2109-2120
76. Zhang, L., Ren, X., Alt, E., Bai, X., Huang, S., Xu, Z., Lynch, P. M., Moyer, M. P., Wen, X. F., and Wu, X. (2010) Chemo-prevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature 464, 1058-1061
77. Mahmood, Z., and Shukla, Y (2010) Death receptors: targets for cancer therapy. Exp. Cell Res. 316, 887-899
78. Choi, S. A., Hwang, S. K., Wang, K. C, Cho, B. K., Phi, J. H., Lee, J. Y., Jung, H. W., Lee, D. H., and Kim, S. K. (2011) Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma. Neurooncology. 13, 61-69
79. Mueller, L. P., Luetzkendorf, J., Widder, M., Nerger, K., Caysa, H., and Mueller, T. (2010) TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo. Cancer Gene Ther. 18, 229-239
80. Lee, R. H., Yoon, N., Reneau, J. C, and Prockop, D.J. (2012) Preactivation of human MSCs with TNF-a enhances tumor-suppressive activity. Cell Stem Cell 11, 825-835
81. Maxson, S., Lopez, E. A., Yoo, D., Danilkovitch-Miagkova, A., and Leroux, M. A. (2012) Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl. Med. 1, 142-149
82. Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y, Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., Breton, E., Davis-Sproul, J., Schulman, I. H., Byrnes, J., Mendizabal, A. M., Lowery, M. H., Rouy, D., Altman, P., Wong Po Foo, C, Ruiz, P., Amador, A., Da Silva, J., McNiece, I. K., Heldman, A. W., George, R., and Lardo, A. (2012) Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transen-docardial injection in patients with ischemic cardiomyopathy. JAMA 308, 2369
83. Richardson, J. D., Nelson, A. J., Zannettino, A. C. W., Gronthos, S., Worthley, S. G., and Psaltis, P.J. (2013) Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. Stem Cell Rev. 9, 281-302
84. Traktuev, D. O., Merfeld-Clauss, S., Li, J., Kolonin, M., Arap, W., Pasqualini, R., Johnstone, B. H., and March, K. L. (2008) A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ. Res. 102, 77-85
85. Islam, M. N., Das, S. R., Emin, M. T., Wei, M., Sun, L., Westphalen, K., Rowlands, D.J., Quadri, S. K., Bhattacharya, S., and Bhattacharya, J. (2012) Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat. Med. 18, 759-765
86. Cselenyák, A., Pankotai, E., Horváth, E. M., Kiss, L., and Lacza, Z. (2010) Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections. BMC Cell Biol. 11, 29
87. Prockop, D.J. (2012) Mitochondria to the rescue. Nat. Med. 18, 653-654
88. Kwan, M. D., Slater, B. J., Wan, D. C., and Longaker, M. T. (2008) Cell-based therapies for skeletal regenerative medicine. Hum. Mol. Genet. 17, R93-R98
89. Bai, X., Pinkernell, K., Song, Y.-H., Nabzdyk, C, Reiser, J., and Alt, E. (2007) Genetically selected stem cells from human adipose tissue express cardiac markers. Biochem. Biophys. Res. Commun. 353, 665-671 (Pubitemid 46048721)
90. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., Leri, A., and Anversa, P. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (Pubitemid 32290358)
91. Alt, E., Pinkernell, K., Scharlau, M., Coleman, M., Fotuhi, P., Nabzdyk, C, Matthias, N., Gehmert, S., and Song, Y H (2010) Effect of freshly isolated autologous tissue resident stromal cells on cardiac function and perfusion following acute myocardial infarction. Int. J. Cardiol. 144, 26-35
92. Bai, X., Yan, Y., Song, Y.-H., Seidensticker, M., Rabinovich, B., Metzele, R., Bankson, J. A., Vykoukal, D., and Alt, E. (2010) Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur. Heart J. 31, 489-501
93. Chugh, A. R., Beache, G. M., Loughran, J. H., Mewton, N., Elmore, J. B., Kajstura, J., Pappas, P., Tatooles, A., Stoddard, M. F., Lima, J. A., Slaughter, M. S., Anversa, P., and Bolli, R. (2012) Administration of cardiac stem cells in patients with ischemic cardiomyopathy: The SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126 (Suppl. 1), S54-S64
94. Metzele, R., Alt, C, Bai, X., Yan, Y., Zhang, Z., Pan, Z., Coleman, M., Vykoukal, J., Song, Y. H., and Alt, E. (2011) Human adipose tissue-derived stem cells exhibit proliferation potential and spontaneous rhythmic contraction after fusion with neonatal rat cardiomyocytes. FASEB J. 25, 830-839
95. Kouris, N. A., Schaefer, J. A., Hatta, M., Freeman, B. T., Kamp, T. J., Kawaoka, Y, and Ogle, B. M. (2012) Directed fusion of mesenchymal stem cells with cardiomyocytes via VSV-G facilitates stem cell programming. Stem Cells Int. 2012, 414038
96. Liu, Y., Wang, L., Kikuiri, T., Akiyama, K., Chen, C., Xu, X., Yang, R., Chen, W., Wang, S., and Shi, S. (2011) Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-7 and TNF-a. Nat. Med. 17, 1594-1601
97. Morigi, M., Introna, M., Imberti, B., Corna, D., Abbate, M., Rota, C., Rottoli, D., Benigni, A., Perico, N., Zoja, C., Rambaldi, A, Remuzzi, A., and Remuzzi, G. (2008) Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26, 2075-2082
98. Yuan, L., Wu, M.-J., Sun, H.-Y, Xiong, J., Zhang, Y, Liu, C. Y, Fu, L. L., Liu, D. M., Liu, H. Q., and Mei, C. L. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury. (2011) Am. J. Physiol. Renal Physiol. 300, F207-F218
99. Sadat, S., Gehmert, S., Song, Y.-H., Yen, Y., Bai, X., Gaiser, S., Klein, H., and Alt, E. (2007) The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun. 363, 674-679 (Pubitemid 47513683)
100. Wang, M., Crisostomo, P. R., Herring, C., Meldrum, K. K., and Meldrum, D. R. (2006) Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R880-R884 (Pubitemid 44498426)
101. Zhang, P., Moudgill, N., Hager, E., Tarola, N., Dimatteo, C., McIlhenny, S., Tulenko, T., and DiMuzio, P.J. (2011) Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease. Stem Cells Dev. 20, 977-988
102. Prockop, D.J., Youn Oh, J. (2011) Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol. Ther. 20, 14-20
103. 2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42-49
104. Carrion, F. A., and Figueroa, F. E. (2011) Mesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue? Stem Cell Res. Ther. 2, 23
105. González, M. A., Gonzalez-Rey, E., Rico, L., Büscher, D., and Delgado, M. (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136, 978-989
106. Akiyama, K., Chen, C., Wang, D., Xu, X., Qu, C., Yamaza, T., Cai, T., Chen, W., Sun, L., and Shi, S. (2012) Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell 10, 544-555
107. Altman, A. M., Prantl, L., Muehlberg, F. L., Song, Y. H., Seidensticker, M., Butler, C. E., and Alt, E. U. (2011) wound microenvironment sequesters adipose-derived stem cells in a murine model of reconstructive surgery in the setting of concurrent distant malignancy. Plast. Reconstruct. Surg. 127, 1467-1477
108. Acharya, A., Das, I., Chandhok, D., and Saha, T. (2010) Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid. Med. Cell Longev. 3, 23-34
109. Xu, J., Lamouille, S., and Derynck, R. (2009) TGF-ß-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172
110. Rangel, M., Karasawa, H., and Castro, N. (2012) Role of cripto-1 during epithelial-to-mesenchymal transition in development and cancer. Am. J. Pathol. 180, 2188-2200
111. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., and Kirchner, T. (2005) Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749 (Pubitemid 41486367)
112. DiMeo, T. A., Anderson, K., Phadke, P., Fan, C., Feng, C., Perou, C. M., Naber, S., and Kuperwasser, C. (2009) A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res. 69, 5364-5373
113. Wang, Z., Li, Y, Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., and Sarkar, F. H. (2009) Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res. 69, 2400-2407
114. Hardy, K. M., Booth, B. W., Hendrix, M.J. C., Salomon, D. S., and Strizzi, L. (2010) ErbB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. Neoplasia 15, 191-199
115. Devarajan, E., Song, Y.-H., Krishnappa, S., and Alt, E. (2012) Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int. J. Cancer 131, 1023-1031
116. Brabletz, T. (2012) MiR-34 and SNAIL: another double-negative feedback loop controlling cellular plasticity/EMT governed by p53. Cell Cycle 11, 215-215
117. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R A., Come, C., Savagner, P., Gitelman, I., Richardson, A., and Weinberg, R. A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (Pubitemid 38798858)
118. May, C. D., Sphyris, N., Evans, K. W., Werden, S. J., Guo, W., and Mani, S. A. (2011) Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 13, 202
119. Mani, S. A., Yang, J., Brooks, M., Schwaninger, G., Zhou, A., Miura, N., Kutok, J. L., Hartwell, K., Richardson, A. L., and Weinberg, R. A. (2007) Mesenchyme forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. U.S.A. 104, 10069-10074 (Pubitemid 47175264)
120. Valina, C., Pinkernell, K., Song, Y.-H., Bai, X., Sadat, S., Campeau, R. J., LeJemtel, T. H., and Alt, E. (2007) Intracoro-nary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 28, 2667-2677 (Pubitemid 350071533)
121. Oh, J. Y., Lee, R. H., Yu, J. M., Ko, J. H., Lee, H. J., Ko, A. Y., Roddy, G. W., and Prockop, D.J. (2012) Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol. Ther. 20, 2143-2152